Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer

被引：0
|
作者：
Heiserman, James P.
Minhas, Zenab
Cheon, Dong-Joo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1761
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1761
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer
    Liu, Dajiang
    Li, Ruiyun
    Wang, Yidan
    Li, Dan
    Li, Leilei
    BMC CANCER, 2024, 24 (01)
  • [32] The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model
    Papaevangelou, Efthymia
    Almeida, Gilberto S.
    Box, Carol
    deSouza, Nandita M.
    Chung, Yuen-Li
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (04) : 992 - 1002
  • [33] Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
    Xu, Lei
    Xu, Ying
    Zheng, Jianbing
    Zhao, Yun
    Wang, Hongcai
    Qi, Yushu
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [34] Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer
    Sun, Li
    Yin, Yajie
    Clark, Leslie H.
    Sun, Wenchuan
    Sullivan, Stephanie A.
    Tran, Arthur-Quan
    Han, Jianjun
    Zhang, Lu
    Guo, Hui
    Madugu, Esther
    Pan, Tommy
    Jackson, Amanda L.
    Kilgore, Joshua
    Jones, Hannah M.
    Gilliam, Timothy P.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    ONCOTARGET, 2017, 8 (38) : 63551 - 63561
  • [35] Attenuation by glutathione of hsp72 gene expression induced by cadmium in cisplatin-resistant human ovarian cancer cells
    Abe, T
    Gotoh, S
    Higashi, K
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (01) : 69 - 76
  • [36] Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines
    Heiserman, James Patrick
    Minhas, Zenab
    Nikpayam, Elahe
    Cheon, Dong-Joo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [37] Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy
    Feng, Xue
    Li, Ling
    Jiang, Hong
    Jiang, Keping
    Jin, Ye
    Zheng, Jianhua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 444 (03) : 376 - 381
  • [38] Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells
    Kang, Dongxu
    Choi, Hye Jin
    Kang, Sujin
    Kim, So Young
    Hwang, Yong-Sic
    Je, Suyeon
    Han, Zhezhu
    Kim, Joo-Hang
    Song, Jae J.
    CELLULAR SIGNALLING, 2015, 27 (04) : 807 - 817
  • [39] ALTERED CROSS-LINKING OF HSP27 BY ZERUMBONE AS A NOVEL STRATEGY FOR OVERCOMING HSP27-MEDIATED RADIORESISTANCE
    Choi, Seo-Hyun
    Lee, Yoon-Jin
    Seo, Woo Duck
    Lee, Hae-June
    Nam, Joo-Won
    Lee, Yoo Jin
    Kim, Joon
    Seo, Eun-Kyoung
    Lee, Yun-Sil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1196 - 1205
  • [40] Alchemix: A novel alkylating anthraquinone with potent activity against anthracycline- and cisplatin-resistant ovarian cancer
    Pors, K
    Paniwnyk, Z
    Teesdale-Spittle, P
    Plumb, JA
    Willmore, E
    Austin, CA
    Patterson, LH
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (07) : 607 - 610
12345